Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists
Patent Number: 5837241
Date of First Priority Issue: Tuesday April 25th, 1995
Date Issued: Tuesday November 17th, 1998
Assignee: Genentech, Inc. (South San Francisco, CA)
Inventors: Ferrara, Napoleone (San Francisco, CA); King, Kathleen (Pacifica, CA); Luis, Elizabeth (San Francisco, CA); Mather, Jennie P. (Millbrae, CA); Paoni, Nicholas F. (Belmont, CA)
From Class: Use
Comments: No comments
This patent covers antagonizing either or both the endothelin receptor and the LIF receptor. Methods of action by which this combination inhibits heart failure may have to do with modulation of stem cell function.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.